BIOVENTUS INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BIOVENTUS INC. (BVS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$4.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-05
- BIOVENTUS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$4.30M, a 173.21% decline from fiscal 2024.
- BIOVENTUS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $5.87M.
- BIOVENTUS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$43.47M.
- BIOVENTUS INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$216.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$4.30M 10-K · filed 2026-03-05 |
| 2024-12-31 | $5.87M 10-K · filed 2025-03-11 |
| 2023-12-31 | -$43.47M 10-K · filed 2024-03-12 |
| 2022-12-31 | -$216.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | -$673.00K 10-K · filed 2022-03-11 |